At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
People coming from daily injectable medications (like certain insulin protocols or BPC-157) sometimes carry the daily injection habit into their tirzepatide protocol
Understanding your lips changes everything Your lips are structurally different from your facial skin
DOI: 10.1038/s41467-020-17648-w.
Volume of Diluent = 99 mg / 10 mg/mL = 9.9 mL So, you would add 9.9 mL of bacteriostatic water to your 99 mg of active 5-Amino-1MQ powder to achieve a 10 mg/mL solution
In receptor-binding and cellular-signaling research, MT-2 acts as a non-selective agonist across the melanocortin receptors: MC1R (associated with melanocyte pigmentation), MC3R and MC4R (central receptors implicated in energy-homeostasis and appetite research), and MC5R